Psychiatry AtlasMedication guide · United States

Antidepressant that acts on two brain messengers; also used for certain pain conditions

Duloxetine (Cymbalta)

Generic name
duloxetine (as duloxetine hydrochloride)
Brand names
Cymbalta
Medication class
SNRI antidepressant; medicine for certain pain conditions
Forms covered
Delayed-release oral capsules

Article updated: 2026-10-24 · Sources last checked: 2026-11-05

Medication Safety Alerts

Look-alike / sound-alike name

Show more (1)
  • Cymbalta can be confused with Symbyax.

FDA Boxed Warning

Duloxetine delayed-release oral capsules.

Duloxetine carries a boxed warning for increased suicidal thoughts and behaviors in children, adolescents and young adults taking antidepressants. Monitor patients of every age for worsening symptoms or new suicidal thinking, especially when starting treatment or changing doses.

Duloxetine treats depression, generalized anxiety, and certain ongoing pain conditions, including diabetic nerve pain and fibromyalgia. This article covers delayed-release capsules, with different age limits for different uses.

Cymbalta (original brand capsules discontinued).

What to expect: Benefits may build over 1 to 4 weeks or longer.

Warning signs
Sources last checked:
2026-11-05

What is this medicine used for?

FDA-approved uses

  • Major depressive disorder — Adults. Treatment of adult major depression; this is not a pediatric depression approval.Delayed-release oral capsules.
  • Generalized anxiety disorder — Adults and children aged 7 years and older. The pediatric approval is specific to generalized anxiety disorder.Delayed-release oral capsules.
  • Diabetic peripheral neuropathic pain — Adults. Pain associated with diabetic peripheral nerve injury.Delayed-release oral capsules.
  • Fibromyalgia — Adults and children aged 13 years and older. The age scope is specific to fibromyalgia and does not extend every indication to teenagers.Delayed-release oral capsules.
  • Chronic musculoskeletal pain — Adults. The supporting studies include chronic low back pain and osteoarthritis-related pain; this is not approval for every cause of pain.Delayed-release oral capsules.

What should I expect?

Benefits may build over 1 to 4 weeks or longer. Mood, anxiety, and pain do not necessarily improve at the same pace; review the symptoms you are treating rather than judging success from an early side effect.

Agree on a follow-up plan when treatment starts. Contact the prescriber if symptoms worsen, side effects disrupt daily life, or there is no useful improvement by the planned review; do not change the dose yourself.

How do I take it safely?

Swallow the delayed-release capsules covered here whole, with or without food. Do not crush, chew, open, or sprinkle them. Ask a pharmacist before using instructions from another duloxetine product.

Keep blood-pressure checks; children need growth monitoring. If you have diabetes, discuss glucose monitoring. Tell the care team about falls, trouble passing urine, or symptoms of low blood sodium, such as new confusion.

MAOI combinations are contraindicated. The label requires at least 14 days after stopping an MAOI before duloxetine, and at least five days after duloxetine before an MAOI; the prescriber must manage these intervals. Do not start it during treatment with linezolid or intravenous methylene blue.

MAOIs without the required separation, including linezolid or intravenous methylene blue in relevant settings.

Avoid use with chronic liver disease, cirrhosis, substantial alcohol use, or severe kidney impairment. Review bipolar episodes, seizures, narrow eye angles, bleeding, and low-sodium risk.

Strong CYP1A2 inhibitors, such as fluvoxamine, can substantially raise duloxetine exposure and should be avoided. CYP2D6 inhibitors can also raise levels. Duloxetine inhibits CYP2D6 and can alter the handling of some tricyclic antidepressants and heart-rhythm medicines; thioridazine is an especially important unsafe combination to review.

Other serotonergic medicines and supplements increase serotonin-syndrome risk. Aspirin, anti-inflammatory pain medicines and anticoagulants can increase bleeding. Heavy alcohol use raises liver risk. Do not combine multiple duloxetine products, even if their brand names differ.

Pregnancy planning should consider untreated illness and medication exposure together. The label describes an association with postpartum bleeding and possible newborn adaptation problems after late-pregnancy exposure. Discuss a plan with the treating clinician rather than suddenly stopping.

Duloxetine enters breast milk; monitor an exposed infant for sedation, poor feeding and poor weight gain. Pediatric approval is limited to generalized anxiety from age seven and fibromyalgia from age thirteen, with growth monitoring. Older adults are more vulnerable to low sodium and falls and have different starting guidance for generalized anxiety.

Stopping duloxetine can cause dizziness, nausea, headache, anxiety, irritability, sweating, sleep problems and unusual sensory symptoms. A gradual, individualized reduction is recommended when possible; severe symptoms need clinical review rather than improvising a taper.

For a missed dose, the Medication Guide advises taking it when remembered unless the next dose is nearly due; then skip it. Do not take two doses together. Ask a pharmacist if the timing is uncertain.

What side effects should I know about?

  • Nausea, dry mouth, constipation and reduced appetite.
  • Sleepiness, fatigue, dizziness and sweating.
  • Sexual difficulties, including changes in interest, orgasm, or ejaculation.

Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.

Which warning signs need help?

  • Fever with agitation or confusion, sweating, diarrhea, stiff or twitching muscles, and a fast heartbeat may be serotonin syndrome. Seek urgent medical care; severe or rapidly worsening symptoms need emergency help.
  • Contact a clinician immediately for yellow skin or eyes, dark urine, blistering or peeling skin, inability to pass urine, or sudden eye pain with vision changes.
  • Seek emergency help for a seizure, collapse, severe confusion, major bleeding, or breathing difficulty. New suicidal thoughts or unusually elevated mood need prompt help; immediate danger requires emergency care.

What else should I know to stay safe?

  • Do not combine with MAO inhibitors. A clinician must allow at least 14 days after an MAOI before duloxetine and at least five days after duloxetine before an MAOI; linezolid and intravenous methylene blue also matter. Avoid use with chronic liver disease, cirrhosis, substantial alcohol use, or severe kidney impairment.
  • Some medicines, including fluvoxamine, can greatly raise duloxetine levels; duloxetine also changes the handling of other drugs. Thioridazine is an especially important unsafe combination. Have serotonin-affecting medicines, supplements, blood thinners, aspirin, anti-inflammatory medicines, and duplicate duloxetine products checked.
  • Check blood pressure and review falls, bipolar episodes, seizures, glaucoma, low sodium, bleeding, and urinary problems. Children need growth monitoring, and diabetes may need closer glucose checks. Abrupt stopping can cause withdrawal; arrange a gradual plan with the prescriber.
  • Discuss pregnancy and breastfeeding. Labeling describes postpartum bleeding and possible newborn adjustment problems after late exposure. An exposed breastfed infant may need monitoring of alertness, feeding, and weight; older adults are more vulnerable to low sodium and falls.

Urgent help and crisis support · Emergency & Crisis Resources (US)

What can help day to day?

  • A prescription for pain does not imply that the pain is imaginary. The medicine affects signaling involved in processing pain as well as mood and anxiety.
  • Delayed-release capsules protect the medicine until it reaches the right part of the digestive tract. Do not open or sprinkle the capsules covered here; another product’s handling instructions may differ.

How does it work?

Duloxetine changes communication between nerve cells by slowing the return of two chemical messengers, serotonin and norepinephrine, into the cells that released them. This affects signaling involved in mood, anxiety and the processing of pain. Its main actions are well described, although the complete route from those actions to symptom relief is not known.

Explore more in Brain & Science: How SNRIs Work: Venlafaxine.

How was this medicine developed?

The FDA approved Cymbalta in 2004. Duloxetine’s U.S. indication list now includes both mental health and pain conditions. These different uses reflect effects on serotonin and norepinephrine signaling, but still have separate age limits and supporting evidence.

How do I say the name?

Duloxetine: doo-LOX-eh-teen. Capital letters show the stressed syllable.

Sources and References

Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.

  1. DailyMed: duloxetine delayed-release capsules, current generic labeling
  2. Duloxetine: patient information and pronunciation
  3. Drugs@FDA: Cymbalta history and discontinued originator products
  4. FDA: Cymbalta prescribing information and Medication Guide
  5. Duloxetine Capsules: Package Insert / Prescribing Info / MOA
  6. DailyMed: Cymbalta originator record and marketing end dates
  7. FDA: Zoloft prescribing information and Medication Guide
  8. FDA: Lexapro prescribing information and Medication Guide
  9. NIH: What Is a Neurotransmitter?
  10. PubChem: Duloxetine parent compound and verified 2D record
  11. ISMP List of Confused Drug Names
  12. Serotonin syndrome: MedlinePlus Medical Encyclopedia
  13. Monitoring a person during and after antidepressant switching – NHS SPS - Specialist Pharmacy Service – The first stop for professional medicines advice

Giving medicine safely to children: family guide (PDF, 3 pages)

How information is checked

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top